Effect of early catheter ablation of atrial fibrillation in patients with heart failure.

Introduction: According to current guidelines, pulmonary vein isolation as first‐line therapy should be considered for patients with atrial fibrillation (AF), however, optimal timing of the procedure is still unknown in patients with heart failure (HF). We aimed to evaluate the effect of early cathe...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Cardiovascular Electrophysiology Vol. 35; no. 7; pp. 1471 - 1480
Autores principales: Tóth, Patrik, Arnóth, Bence, Komlósi, Ferenc, Szegedi, Nándor, Salló, Zoltán, Perge, Péter, Osztheimer, István, Merkely, Béla, Gellér, László, Nagy, Klaudia Vivien
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell Jul2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=178395178&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 178395178
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10453873
        GSB
      jtl: Journal of Cardiovascular Electrophysiology
      issn: 10453873
      maglogo: Y
    pubinfo:
      dt: Jul2024
      vid: 35
      iid: 7
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        178395178
        177477311
        178395178
        178395178
        10.1111/jce.16300
        178395178
      ppf: 1471
      ppct: 9
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: Effect of early catheter ablation of atrial fibrillation in patients with heart failure.
      aug:
        au:
          Tóth, Patrik
          Arnóth, Bence
          Komlósi, Ferenc
          Szegedi, Nándor
          Salló, Zoltán
          Perge, Péter
          Osztheimer, István
          Merkely, Béla
          Gellér, László
          Nagy, Klaudia Vivien
        affil: Heart and Vascular Center, Semmelweis University, Budapest, Hungary
      sug:
        subj:
          Catheter Ablation Adverse Effects
          Catheter Ablation Mortality
          Atrial Fibrillation Diagnosis
          Atrial Fibrillation Mortality
          Atrial Fibrillation Surgery
          Heart Failure Complications
          Heart Failure Mortality
          Ventricular Function, Left
          Treatment Outcomes
          Human
          Female
          Male
          Middle Age
          Aged
          Retrospective Design
          Prospective Studies
          Nonexperimental Studies
          Atrial Fibrillation Physiopathology
          Heart Failure Physiopathology
          Pulmonary Veins Physiopathology
          Action Potentials
          Heart Rate
          Pulmonary Veins Surgery
          Recurrence
          Stroke Volume
          Patient Care
          Atrial Fibrillation Risk Factors
          Risk Assessment
          Comorbidity
          Cardiac Patients
          Descriptive Statistics
          Funding Source
          Middle Aged: 45-64 years
          Aged: 65+ years
          Female
          Male
      ab: Introduction: According to current guidelines, pulmonary vein isolation as first‐line therapy should be considered for patients with atrial fibrillation (AF), however, optimal timing of the procedure is still unknown in patients with heart failure (HF). We aimed to evaluate the effect of early catheter ablation (CA) in patients with HF and left ventricular ejection fraction (LVEF) below 50%. Methods: We analyzed data from a structured registry comprising 227 patients with paroxysmal or persistent AF and HF with LVEF < 50% who underwent radiofrequency CA between 2015 and 2022. Early CA was defined as a procedure performed within 12 months of AF diagnosis. The median follow‐up duration was 1748 (1176.3–2353.5) days, with a minimum follow‐up of 365 days. Our endpoints were AF recurrence after a 3‐months blanking period and all‐cause mortality. Results: Among the 227 patients with a median age of 64.3 years, 97 (42.7%) experienced AF recurrence and 55 (24.2%) died during the follow‐up period. The median LVEF was 40% for early CA and 38% for delayed CA (p =.053). Early CA significantly reduced AF recurrence (HR = 0.25 [0.15–0.42], p <.001), however, the timing of procedure did not affect all‐cause mortality (p =.16). These findings were consistent regardless of AF subtype or the burden of comorbidities, as assessed by the CHA2DS2‐VASc score. Conclusion: The timing of CA of AF appears to be an important factor in patients with HF. Early CA reduced AF recurrence, although it does not impact all‐cause mortality. We found similar results regardless of AF subtype or burden of comorbidities.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N